휴메딕스

200670KOSDAQ

75.3 / 100

Reference Date: 2026-09-08

Financial Score35.0 / 40

News Sentiment20.3 / 25

Momentum6.0 / 20

Disclosure14.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Slightly down 3.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HumeDx operates in two main business segments: the Aesthetic Division, producing fillers, botulinum toxin, cosmetics, and medical devices, and the CMO Division, specializing in specialty pharmaceuticals, osteoarthritis treatments, and raw material production. The company leverages its proprietary HI (High molecular Ideal reticulated matrix) technology to develop long-lasting fillers and high-performance cosmetics using pharmaceutical-grade HA and PDRN.

Number of Employees

377people

Average Salary

56.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

5.59Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

0.97Industry Average 1.204.0Point

In line with industry avg

ROE

19.61Industry Average 8.007.0Point

2.5x industry avg (excellent)

Debt Ratio

1.15Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.7% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲6.9% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 17.6% (improving, 3yr)

Detailed News Sentiment

15 totalPositive 15Neutral 0Negative 0Average Sentiment Score 81

Positive
휴온스그룹, 생산시설 확대·해외 거점 강화…제조 경쟁력 높인다
휴메딕스의 생산시설 확장과 해외 거점 강화로 제조 경쟁력이 향상되어 긍정적 영향 기대.
Positive
"동남아시장 강화"…휴메딕스, 국제 미용학회 참가
휴메딕스의 국제 미용학회 참가로 동남아시아 시장 강화 및 HA 필러 홍보 성공 기대.
Positive
"의료진과 소통"…휴메딕스, 학술 프로그램 참여
휴메딕스의 학술 프로그램 참여로 인해 전문성 강화 및 시장 신뢰도 상승 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 25,800Won52-week high 69,30052-week low 22,600

1-month return2.0Point

1m -3.19% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

4 totalPositive 2Neutral 2Negative 0

Neutral반기보고서 (2026.06)2026-08-14
Neutral기업설명회(IR)개최2026-08-14
Positive중간(분기)배당을위한주주명부폐쇄(기준일)결정2026-08-11
Positive현금ㆍ현물배당결정 (분기배당)2026-08-11